LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LENSAR (Nasdaq: LNSR) announced the granting of inducement awards to three newly-hired non-executive employees. The compensation package consists of 660 restricted stock units (RSUs) in total, approved by the independent members of LENSAR's board of directors.
The RSUs were granted on September 2, 2025, under LENSAR's 2024 Employment Inducement Incentive Award Plan. Each RSU represents one share of common stock and will vest in four equal annual installments, contingent upon continued employment with the company through each vesting date.
LENSAR (Nasdaq: LNSR) ha comunicato la concessione di premi di inserimento a tre neoassunti non dirigenti. Il pacchetto retributivo comprende in totale 660 unità di azioni vincolate (RSU), approvate dai membri indipendenti del consiglio di amministrazione di LENSAR.
Le RSU sono state attribuite il 2 settembre 2025, ai sensi del Piano di incentivazione per l'assunzione 2024 di LENSAR. Ciascuna RSU corrisponde a una azione ordinaria e maturerà in quattro rate annuali uguali, subordinate alla permanenza in servizio presso la società fino a ciascuna data di maturazione.
LENSAR (Nasdaq: LNSR) anunció la concesión de premios de inducción a tres empleados recientemente contratados que no son ejecutivos. El paquete de compensación consta en total de 660 unidades restringidas de acciones (RSU), aprobadas por los miembros independientes del consejo de administración de LENSAR.
Las RSU se otorgaron el 2 de septiembre de 2025, en virtud del Plan de Premios de Incentivo por Contratación 2024 de LENSAR. Cada RSU representa una acción ordinaria y se consolidará en cuatro abonos anuales iguales, condicionados a la continuidad del empleo en la compañía hasta cada fecha de consolidación.
LENSAR (Nasdaq: LNSR)는 비임원으로 새로 채용된 세 명의 직원에게 유인 보상(인듀스먼트 어워드)을 부여했다고 발표했습니다. 보상 패키지는 독립 이사들에 의해 승인된 총 660주 제한부 주식 단위(RSU)로 구성됩니다.
RSU는 2025년 9월 2일에 부여되었으며 LENSAR의 2024년 채용 인센티브 보상 계획에 따른 것입니다. 각 RSU는 보통주 1주를 의미하며 고용 상태가 각 베스팅 날짜까지 유지되는 것을 조건으로 4회에 걸쳐 연간 동일 비율로 베스트됩니다.
LENSAR (Nasdaq: LNSR) a annoncé l'attribution de primes d'incitation à trois employés nouvellement embauchés non dirigeants. Le package de rémunération comprend au total 660 unités d'actions restreintes (RSU), approuvées par les administrateurs indépendants du conseil d'administration de LENSAR.
Les RSU ont été attribuées le 2 septembre 2025, dans le cadre du Plan d'attribution d'incitations à l'embauche 2024 de LENSAR. Chaque RSU correspond à une action ordinaire et sera acquise en quatre versements annuels égaux, sous réserve de la poursuite de l'emploi au sein de la société jusqu'à chaque date d'acquisition.
LENSAR (Nasdaq: LNSR) gab die Gewährung von Anreizzuwendungen an drei neu eingestellte nicht-exekutive Mitarbeiter bekannt. Das Vergütungspaket umfasst insgesamt 660 Restricted Stock Units (RSUs), genehmigt durch die unabhängigen Mitglieder des Verwaltungsrats von LENSAR.
Die RSUs wurden am 2. September 2025 gewährt, gemäß dem LENSAR 2024 Employment Inducement Incentive Award Plan. Jede RSU entspricht einer Stammaktie und wird in vier gleichen jährlichen Raten unverfallbar, vorbehaltlich der fortgesetzten Anstellung bei der Gesellschaft bis zu den jeweiligen Vesting-Terminen.
- None.
- None.
ORLANDO, Fla., Sept. 02, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR’s board of directors granted three newly-hired non-executive employees an aggregate of 660 restricted stock units (“RSUs”). The RSUs were granted as of September 2, 2025, as inducement for each such employee commencing employment with the Company. The RSUs were granted in accordance with Nasdaq Listing Rule 5635(c)(4).
Each RSU represents a contingent right to receive one share of the Company’s common stock. The RSUs vest in four substantially equal installments on each anniversary of the grant date, subject to the new employee’s continued service with the Company through the applicable vesting date. The RSUs are subject to the terms and conditions of LENSAR’s 2024 Employment Inducement Incentive Award Plan and a restricted stock unit agreement covering the grant.
About LENSAR
LENSAR is a commercial-stage medical device company focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the procedure. LENSAR has developed its ALLY Robotic Cataract Laser System™ as a compact, highly ergonomic system utilizing an extremely fast dual-modality laser and integrating AI into proprietary imaging and software. ALLY is designed to transform premium cataract surgery by utilizing LENSAR’s advanced robotic technologies with the ability to perform the entire procedure in a sterile operating room or in-office surgical suite, delivering operational efficiencies and reduced overhead. ALLY includes LENSAR’s proprietary Streamline® software technology, designed to guide surgeons to achieve better outcomes.
Contacts: | Lee Roth / Cameron Radinovic |
Thomas R. Staab, II, CFO | Burns McClellan for LENSAR |
ir.contact@lensar.com | lroth@burnsmc.com / cradinovic@burnsmc.com |
